Status:
UNKNOWN
Histomolecular Profiles of Gliomas in Children and Adolescent/Young Adults
Lead Sponsor:
Centre Hospitalier Universitaire, Amiens
Conditions:
Histological
Molecular Sequence Variation
Eligibility:
All Genders
Up to 25 years
Brief Summary
In the last decades, many advances have been made in the field of genetic abnormalities of glial and glioneuronal brain tumors. In the 2016 World Health organization (WHO) Classification of Tumors of ...
Eligibility Criteria
Inclusion
- Male or female patient
- Patient treated in the Amiens University Hospital
- Patient treated for a glial or glioneuronal brain tumor according to the 2016 WHO Classification of Tumors of the Central Nervous System ("diffuse oligodendroglia or astrocytoma tumour," "another astrocytic tumor," "another glioma" or a "mixed neuronal or glioneuronal tumour").
- Diagnosis histologically confirmed or formally established by radiologist.
- Diagnosis established between January 1, 2008 and December 31, 2020.
- No patient opposition (from adult patient, or from the holder of parental authority of the minor patient).
Exclusion
- Uncertain diagnosis
- Patient opposition (from adult patient, or from the holder of parental authority of the minor patient).
Key Trial Info
Start Date :
June 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2023
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT04916015
Start Date
June 1 2021
End Date
October 1 2023
Last Update
February 10 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Amiens
Amiens, France, 80480